Ignacio Mena

Title: Innovations of Ignacio Mena in Viral Research

Introduction

Ignacio Mena is a notable inventor based in New York, NY (US), recognized for his contributions to the field of viral research. He holds a patent that addresses significant health concerns related to respiratory diseases. His work focuses on the development of recombinant Newcastle disease viruses for the prevention of respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) diseases.

Latest Patents

Mena's patent, titled "Recombinant Newcastle disease viruses and uses thereof for the prevention of RSV disease or human metapneumovirus disease," describes innovative recombinant Newcastle disease viruses (NDVs). These NDVs comprise a packaged genome that includes a transgene encoding either the RSV F protein or the hMPV F protein. Additionally, the patent outlines NDVs that contain a chimeric F protein, which combines elements from both RSV and NDV proteins. This groundbreaking research provides a potential immunization strategy against RSV and hMPV, contributing to the prevention of related diseases.

Career Highlights

Throughout his career, Ignacio Mena has worked with prestigious institutions, including the Icahn School of Medicine at Mount Sinai and Rutgers, the State University of New Jersey. His experience in these organizations has allowed him to collaborate with leading experts in the field and advance his research on viral diseases.

Collaborations

Mena has collaborated with notable colleagues such as Joan E. Durbin and Russell K. Durbin. Their joint efforts have contributed to the development of innovative solutions in viral research.

Conclusion

Ignacio Mena's work in developing recombinant Newcastle disease viruses represents a significant advancement in the prevention of respiratory diseases. His contributions to the field highlight the importance of innovative research in addressing public health challenges.